|
US4751180A
(en)
|
1985-03-28 |
1988-06-14 |
Chiron Corporation |
Expression using fused genes providing for protein product
|
|
US4935233A
(en)
|
1985-12-02 |
1990-06-19 |
G. D. Searle And Company |
Covalently linked polypeptide cell modulators
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
US6267964B1
(en)
|
1989-08-01 |
2001-07-31 |
Affibody Technology Sweden Ab |
Stabilized protein or peptide conjugates able to bond albumin having extended biological half-lives
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
GB8918616D0
(en)
|
1989-08-15 |
1989-09-27 |
Univ Glasgow |
Herpes simplex virus type 1 mutant
|
|
US20020164782A1
(en)
|
1999-02-10 |
2002-11-07 |
Gregory Richard J. |
Adenovirus vectors for gene therapy
|
|
JPH04292169A
(ja)
|
1991-03-19 |
1992-10-16 |
Sekisui Chem Co Ltd |
ハイブリッド型人工膵臓
|
|
US5418618A
(en)
|
1992-03-09 |
1995-05-23 |
Mita Industrial Co., Ltd. |
Tone processing method for forming a halftone image
|
|
US5804413A
(en)
|
1992-07-31 |
1998-09-08 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus strains for gene transfer
|
|
DE59403475D1
(de)
|
1993-09-15 |
1997-08-28 |
Oce Printing Systems Gmbh |
Anordnung zur erzeugung eines rasterbildes auf einem lichtempfindlichen aufzeichunungsträger
|
|
EP0739488A1
(en)
|
1994-01-14 |
1996-10-30 |
Genentech, Inc. |
Antagonists to insulin receptor tyrosine kinase inhibitor
|
|
GB9415319D0
(en)
|
1994-07-29 |
1994-09-21 |
Medical Res Council |
HSV viral vector
|
|
US5846782A
(en)
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
|
US6825396B2
(en)
|
1996-06-12 |
2004-11-30 |
Board Of Trustees Operating Michigan State University |
Methods for tissue specific synthesis of protein in eggs of transgenic hens
|
|
US6455495B1
(en)
|
1997-02-14 |
2002-09-24 |
The Salk Institute For Biological Studies |
Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
WO1999006583A1
(en)
|
1997-07-31 |
1999-02-11 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Targeted hsv vectors
|
|
JP2001520009A
(ja)
|
1997-10-16 |
2001-10-30 |
ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド |
鳥の導入遺伝子についてのマグナム特異的プロモーターを含むベクター
|
|
US5932465A
(en)
|
1997-10-16 |
1999-08-03 |
Icos Corporation |
Phosphodiesterase 8A
|
|
US20040019923A1
(en)
|
1997-10-16 |
2004-01-29 |
Ivarie Robert D. |
Exogenous proteins expressed in avians and their eggs
|
|
JP4584447B2
(ja)
|
1997-11-07 |
2010-11-24 |
トリリアム・セラピューティクス・インコーポレイテッド |
免疫調節のための方法および組成物
|
|
US6894022B1
(en)
|
1998-08-27 |
2005-05-17 |
Eidgenossische Technische Hochschule Zurich |
Growth factor modified protein matrices for tissue engineering
|
|
US6272859B1
(en)
|
1998-10-02 |
2001-08-14 |
Caterpillar Inc. |
Device for controlling a variable geometry turbocharger
|
|
US6043056A
(en)
|
1998-11-06 |
2000-03-28 |
Incyte Pharmaceuticals, Inc. |
Cell surface glycoproteins
|
|
CA2353550A1
(en)
|
1998-12-03 |
2000-06-08 |
Histatek, Llc |
Small peptides and methods for treatment of asthma and inflammation
|
|
ATE403715T1
(de)
|
1999-08-09 |
2008-08-15 |
Targeted Genetics Corp |
Erhöhung der expression einer einzelsträngigen, heterologen nukleotidsequenz von einem rekombinanten viralen vektor durch ausgestaltung der sequenz in einer art und weise, dass basenpaarungen innerhalb der sequenz entstehen
|
|
JP3983449B2
(ja)
|
1999-10-15 |
2007-09-26 |
株式会社リコー |
パルス幅変調回路、光書き込み装置及び画像形成装置
|
|
ES2270893T3
(es)
|
1999-12-24 |
2007-04-16 |
Genentech, Inc. |
Procedimiento y composiciones para prolongar la vida media de compuestos bioactivos.
|
|
DE60140349D1
(de)
|
2000-02-23 |
2009-12-17 |
Pxe Internat Inc |
Methoden und zusammensetzungen zur diagnose und behandlung von pseudoxanthoma elasticum und ähnlichen zuständen
|
|
JP2001274989A
(ja)
|
2000-03-27 |
2001-10-05 |
Ricoh Co Ltd |
画像処理装置及び画像処理方法並びにプリンタ出力装置
|
|
DE20121960U1
(de)
|
2000-04-06 |
2004-01-15 |
Epigenomics Ag |
Nukleinsäuren für die Diagnose von mit Metastase assoziierten Krankheiten
|
|
US20040030167A1
(en)
|
2000-08-08 |
2004-02-12 |
Hiroaki Takayama |
3-Methyl-20-epi-vitamin d derivatives
|
|
US6521645B2
(en)
|
2000-11-20 |
2003-02-18 |
The University Of Kansas Medical Center |
Methods for the treatment and prevention of urinary stone disease
|
|
PT1355919E
(pt)
|
2000-12-12 |
2011-03-02 |
Medimmune Llc |
Moléculas com semivida longa, composições que as contêm e suas utilizações
|
|
US20020108132A1
(en)
|
2001-02-02 |
2002-08-08 |
Avigenics Inc. |
Production of a monoclonal antibody by a transgenic chicken
|
|
CA2440582A1
(en)
|
2001-03-09 |
2002-10-03 |
Dyax Corp. |
Serum albumin binding moieties
|
|
WO2002092020A2
(en)
|
2001-03-23 |
2002-11-21 |
The Burnham Institute |
Compositions and methods for modulating bone mineral deposition
|
|
US7888372B2
(en)
|
2001-03-23 |
2011-02-15 |
National Institutes Of Health (Nih) |
Compositions and methods for modulating bone mineral deposition
|
|
US20030191073A1
(en)
|
2001-11-07 |
2003-10-09 |
Challita-Eid Pia M. |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
|
|
AU2002324700A1
(en)
|
2001-08-14 |
2003-03-03 |
Bayer Ag |
Nucleic acid and amino acid sequences involved in pain
|
|
US7312374B2
(en)
|
2001-09-18 |
2007-12-25 |
Avigenics, Inc |
Production of a transgenic avian by cytoplasmic injection
|
|
IL161268A0
(en)
|
2001-11-07 |
2004-09-27 |
Agensys Inc |
Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same
|
|
US6875588B2
(en)
|
2001-11-30 |
2005-04-05 |
Avigenics, Inc. |
Ovomucoid promoter and methods of use
|
|
US7335761B2
(en)
|
2001-11-30 |
2008-02-26 |
Avigenics, Inc. |
Avian gene expression controlling regions
|
|
US7294507B2
(en)
|
2001-11-30 |
2007-11-13 |
Avigenics, Inc. |
Ovomucoid promoters and methods of use
|
|
US7858297B2
(en)
|
2001-12-18 |
2010-12-28 |
Centre National De La Recherche Scientifique Cnrs |
Chemokine-binding protein and methods of use
|
|
WO2003072593A2
(en)
|
2002-02-21 |
2003-09-04 |
University Of Virginia Patent Foundation |
Bone targeting peptides
|
|
US20080108560A1
(en)
|
2002-03-05 |
2008-05-08 |
Eli Lilly And Company |
Heterologous G-Csf Fusion Proteins
|
|
CA2490009A1
(en)
|
2002-06-21 |
2003-12-31 |
Dyax Corporation |
Serum protein-associated target-specific ligands and identification method therefor
|
|
US20040224893A1
(en)
|
2003-05-06 |
2004-11-11 |
Li-Hsien Wang |
Methods of using IL-1 antagonists to treat neointimal hyperplasia
|
|
US20050090001A1
(en)
|
2003-10-07 |
2005-04-28 |
Parker Stephen H. |
Cell lines and methods for producing proteins
|
|
EP1729795B1
(en)
|
2004-02-09 |
2016-02-03 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
HUE055861T2
(hu)
|
2004-04-21 |
2021-12-28 |
Alexion Pharma Inc |
Csontbejuttató konjugátumok és azok alkalmazási módszere fehérjék csonthoz kötéséhez
|
|
US9055984B2
(en)
|
2004-04-21 |
2015-06-16 |
DePuy Synthes Products, Inc. |
Sternal reconstruction system
|
|
US20050287284A1
(en)
|
2004-06-28 |
2005-12-29 |
Shukla Triveni P |
Processed meats comprising dietary fiber gel
|
|
WO2006039480A2
(en)
|
2004-09-29 |
2006-04-13 |
The Burnham Institute For Medical Research |
Tissue non-specific alkaline phosphate (tnap): a therapeutic target for arterial calcification
|
|
EP1805213B1
(en)
|
2004-10-28 |
2015-11-18 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain
|
|
US8110660B2
(en)
|
2004-11-19 |
2012-02-07 |
Ono Pharmaceutical Co., Ltd. |
Soluble ENPP4 protein
|
|
GB0426397D0
(en)
|
2004-12-01 |
2005-01-05 |
Health Prot Agency |
Fusion proteins
|
|
US7456683B2
(en)
|
2005-06-09 |
2008-11-25 |
Panasonic Corporation |
Amplitude error compensating device and quadrature skew error compensating device
|
|
US20080311101A1
(en)
|
2005-06-10 |
2008-12-18 |
Shenoy Bhami C |
Method to Reduce Oxalate Concentration by Administration of Oxalate Oxidase Crystals
|
|
EP1736553A1
(en)
|
2005-06-17 |
2006-12-27 |
Centre National De La Recherche Scientifique |
ENPP1 (PC-1) gene haplotype associated with the risk of obesity and type 2 diabetes and their applications
|
|
US20090180989A1
(en)
|
2005-10-05 |
2009-07-16 |
Synageva Biopharma Corp. |
Compositions and methods for delivering nucleotide sequences to vertebrates
|
|
US11039942B2
(en)
|
2006-06-13 |
2021-06-22 |
Sino Medical Sciences Technology Inc. |
Drug eluting stent and method of use of the same for enabling restoration of functional endothelial cell layers
|
|
ES2412254T3
(es)
|
2006-08-02 |
2013-07-10 |
Altus Pharmaceuticals Inc. |
Oxalato-descarboxilasa cristalizada y métodos de uso
|
|
EP2069402A2
(en)
|
2006-09-08 |
2009-06-17 |
Ablynx N.V. |
Serum albumin binding proteins with long half-lives
|
|
US20100055736A1
(en)
|
2006-11-28 |
2010-03-04 |
Proyecto De Biomedicina Cima, S.L. |
Viral vector and uses thereof
|
|
US20080273206A1
(en)
|
2007-04-23 |
2008-11-06 |
University Of South Carolina |
Biomimetic Mineralization Method and System
|
|
PL2158319T4
(pl)
|
2007-05-11 |
2016-04-29 |
Alexion Pharma Inc |
Fosfataza alkaliczna kierowana do kości, zestawy i zastosowanie
|
|
WO2008157593A2
(en)
|
2007-06-18 |
2008-12-24 |
Oregon Health & Science University |
Protein c for use in maintaining hemostasis
|
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
|
GB0803352D0
(en)
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
|
AR071885A1
(es)
|
2008-05-23 |
2010-07-21 |
Wyeth Corp |
Proteinas de union al receptor de interleuquina 21
|
|
JP4888439B2
(ja)
|
2008-05-30 |
2012-02-29 |
ブラザー工業株式会社 |
画像読取装置および原稿サイズ決定プログラム
|
|
CA2788682C
(en)
|
2010-02-05 |
2019-03-05 |
The University Of North Carolina At Chapel Hill |
Compositions and methods for enhanced parvovirus transduction
|
|
WO2011113027A2
(en)
|
2010-03-12 |
2011-09-15 |
Synageva Biopharma Corp |
Npp1 fusion proteins
|
|
RU2601154C2
(ru)
|
2011-03-11 |
2016-10-27 |
Синаджива Байофарма Корп |
Гибридные белки npp1
|
|
EP2691084A1
(en)
|
2011-03-29 |
2014-02-05 |
Beta-Cell N.V. |
Method for encapsulated therapeutic products and uses thereof
|
|
WO2013074615A1
(en)
|
2011-11-14 |
2013-05-23 |
Yale University |
Compositions and methods for modulating coagulation
|
|
JP2016509594A
(ja)
|
2013-01-04 |
2016-03-31 |
レンペックス・ファーマシューティカルズ・インコーポレイテッド |
ボロン酸誘導体及びその治療的使用
|
|
JP6894664B2
(ja)
|
2013-02-13 |
2021-06-30 |
イエール ユニバーシティ |
病的な石灰化および骨化を治療するための組成物および方法
|
|
US20160184458A1
(en)
|
2013-03-14 |
2016-06-30 |
Shire Human Genetic Therapies, Inc. |
Mrna therapeutic compositions and use to treat diseases and disorders
|
|
ES2847383T3
(es)
|
2013-03-15 |
2021-08-03 |
Atyr Pharma Inc |
Conjugados de Fc-histidil-ARNt sintetasa
|
|
ES2523016B1
(es)
|
2013-05-20 |
2015-09-09 |
3P Biopharmaceuticals |
Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes
|
|
EP3492106B1
(en)
|
2013-08-09 |
2021-02-17 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
EP3046506B1
(en)
|
2013-09-19 |
2021-04-28 |
Universitätsspital Basel |
Artificial vascular graft
|
|
ES2762672T3
(es)
|
2014-02-19 |
2020-05-25 |
Bioasis Technologies Inc |
Proteínas de fusión de P97-IDS
|
|
GB2526339A
(en)
|
2014-05-21 |
2015-11-25 |
Imp Innovations Ltd |
Lentiviral vectors
|
|
CA2960912A1
(en)
|
2014-09-16 |
2016-03-24 |
Universitat Autonoma De Barcelona |
Adeno-associated viral vectors for the gene therapy of metabolic diseases
|
|
USRE49529E1
(en)
|
2014-12-19 |
2023-05-16 |
Inozyme Pharma, Inc. |
Methods of treating tissue calcification
|
|
US10926006B2
(en)
|
2015-02-26 |
2021-02-23 |
Remodeless Cv Ltd |
Drug eluting stent
|
|
PL3298140T3
(pl)
|
2015-05-19 |
2024-11-12 |
Yale University |
Kompozycje do leczenia patologicznych stanów zwapnienia i sposoby ich stosowania
|
|
KR102821290B1
(ko)
|
2015-11-12 |
2025-06-18 |
더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 |
근이영양증을 치료하는 방법
|
|
JP2018537093A
(ja)
|
2015-11-20 |
2018-12-20 |
イエール ユニバーシティ |
異所性石灰化障害を治療するための組成物およびそれを使用する方法
|
|
US11078247B2
(en)
|
2016-05-04 |
2021-08-03 |
Curevac Ag |
RNA encoding a therapeutic protein
|
|
EP3827835A1
(en)
|
2016-06-16 |
2021-06-02 |
Inozyme Pharma, Inc. |
Methods of treating myointimal proliferation
|
|
JP2019532915A
(ja)
|
2016-08-05 |
2019-11-14 |
イエール ユニバーシティ |
小児鎌状赤血球貧血患者における脳卒中予防のための組成物および方法
|
|
IL268198B2
(en)
|
2017-02-27 |
2024-10-01 |
Shattuck Labs Inc |
Tigit- and light-based chimeric proteins
|
|
WO2019067502A1
(en)
|
2017-09-27 |
2019-04-04 |
Alexion Pharmaceuticals, Inc. |
METHODS FOR IMPROVING CARDIOVASCULAR FUNCTION AND TREATING CARDIOVASCULAR DISEASE USING RECOMBINANT ECTO-NUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE
|
|
CA3099266A1
(en)
|
2018-05-08 |
2019-11-14 |
Yale University |
Compositions and methods for reducing progression of nephrolithiasis
|